< BACK TO NEWS
positiveSYS.SOURCE: New Scientist• 2026-11-19T17:25:33Z

Adenovirus Therapy Shows Promise in Halting Pancreatic Cancer Progression

A genetically engineered adenovirus targeting COX-2 enzyme showed efficacy in halting pancreatic cancer progression in three patients during an early trial, with tumours remaining stable without growth. The virus selectively replicates in cancer cells, offering a potential new approach for treating this aggressive cancer type.

Comments

Read original article

*** END OF TRANSMISSION ***